Charles D. Claude
46Patents
15h-index
41Co-inventors
77Inventor score
Filing activity: Jul 29, 1999 → Oct 3, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6780424B2 | Controlled morphologies in polymer drug for release of drugs from polymer films | Human Necessities | 127 | Expired |
| US6702744B2 | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery | Emerging Cross-Sectional Technologies | 94 | Expired |
| US6994867B1 | Biocompatible carrier containing L-arginine | Human Necessities | 86 | Expired |
| US7776926B1 | Biocompatible coating for implantable medical devices | Human Necessities | 60 | Expired |
| US6946173B2 | Catheter balloon formed of ePTFE and a diene polymer | Emerging Cross-Sectional Technologies | 57 | Expired |
| US7641643B2 | Methods and compositions to treat myocardial conditions | Human Necessities | 41 | Active |
| US7361368B2 | Device and method for combining a treatment agent and a gel | Human Necessities | 37 | Expired |
| US7201935B1 | Plasma-generated coatings for medical devices and methods for fabricating thereof | Performing Operations; Transporting | 37 | Expired |
| US7560492B1 | Polysulfone block copolymers as drug-eluting coating material | Human Necessities | 36 | Expired |
| US7261946B2 | Block copolymers of acrylates and methacrylates with fluoroalkenes | Emerging Cross-Sectional Technologies | 35 | Expired |
| US8521259B2 | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery | Emerging Cross-Sectional Technologies | 34 | Active |
| US7637941B1 | Endothelial cell binding coatings for rapid encapsulation of bioerodable stents | Human Necessities | 25 | Expired |
| US6512606B1 | Optical storage media and method for optical data storage via local changes in reflectivity of a format grating | Physics | 22 | Expired |
| US7396582B2 | Medical device chemically modified by plasma polymerization | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7795467B1 | Bioabsorbable, biobeneficial polyurethanes for use in medical devices | Chemistry; Metallurgy | 17 | Active |
| US9561309B2 | Antifouling heparin coatings | Chemistry; Metallurgy | 15 | Active |
| US7056523B1 | Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine | Performing Operations; Transporting | 15 | Expired |
| US9656030B1 | System for the injection of cells and/or biologically active materials into coronary arteries for therapeutic purposes | Human Necessities | 14 | Active |
| US8123799B1 | Modified implantable device surface and a method of making the same | Performing Operations; Transporting | 13 | Expired |
| US6793960B1 | Medical device having surface modification with superoxide dismutase mimic | Emerging Cross-Sectional Technologies | 13 | Expired |
| US8383158B2 | Methods and compositions to treat myocardial conditions | Human Necessities | 13 | Expired |
| US7854944B2 | Tissue regeneration | Human Necessities | 12 | Active |
| US8309112B2 | Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same | Human Necessities | 9 | Active |
| US7441513B1 | Plasma-generated coating apparatus for medical devices and a method of coating deposition | Human Necessities | 7 | Expired |
| US7364748B2 | Controlled morphologies in polymer drug for release of drugs from polymer films | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.